@travizack.bsky.social and Varun from OE talk AI and the future of medical information on the STAT-AI podcast:
open.spotify.com/episode/121y...
@openevidence.bsky.social
@travizack.bsky.social and Varun from OE talk AI and the future of medical information on the STAT-AI podcast:
open.spotify.com/episode/121y...
We have a new deepconsult feature that is a bit more directed at literature review.
04.07.2025 14:41 β π 2 π 0 π¬ 0 π 0Happy first day!
To all interns, residents, fellows, and new attendings.
We are building specialty specific learning communities at OE. If you are interested in joining peers and learning together with Openevidence, shoot us an email at md_community@openevidence.com
Dr. Atul Butte was laid to rest today. His large shoulders and larger vision have been foundational to all AI can and will accomplish in healthcare.
His family is requesting those interested to please consider supporting research on mpnst here: giving.ucsf.edu/fund/maligna...
Selfie of Lancet Senior Executive Editor, Vania Wisdom, and Acting Deputy Editor at The Lancet Oncology, Kat Gourd. Both are Lancet Oncology Ambassadors, attending the American Society of Clinical Oncology (ASCO) conference in Chicago, USA.
π Our editors are on-site at #ASCO25, Chicago.
Weβre excited to be part of this gathering of global cancer expertsβcome & meet us.
βContact the Editorβ details below, in-thread π§΅ @ascocancer.bsky.social
Hello from the City of Lakes! Weβre thrilled to welcome thousands of members of the ob-gyn community to the 2025 Annual Clinical & Scientific Meeting. From the heart of the Midwest, weβre kicking off a weekend of connection, learning, and inspiration. Share the excitement using #ACOG2025!
15.05.2025 22:01 β π 9 π 2 π¬ 1 π 1As for the safety, I asked @openevidence.bsky.social which is a chatbot trained on the professional medical literature. The current thinking is that it is not ready for primetime. www.openevidence.com/ask/2ca4fd30...
13.05.2025 01:00 β π 2 π 2 π¬ 1 π 0Welcome JAMA!!
13.05.2025 01:26 β π 1 π 0 π¬ 0 π 0we are now offering free CME credits just by OE in yuour normal practice:
www.openevidence.com/announcement...
I don't know... How do you feel :)
17.04.2025 22:44 β π 0 π 0 π¬ 0 π 0Congratulations π excited to welcome them to UCSF family
21.03.2025 19:47 β π 0 π 0 π¬ 0 π 0So thrilled to welcome this extraordinary group of 64 young physicians to @UCSF and @UCSFimresidency. A great day!
(UCPC=UCSF Health-based primary care program; SFGH=San Francisco General-based primary care; PSTP=physician-scientist training program) @UCSFIMChiefs @UCSFDOM
@travizack.bsky.social and Varun from OE talk AI and the future of medical information on the STAT-AI podcast:
open.spotify.com/episode/121y...
www.openevidence.com/ask/88013027...
15.02.2025 01:26 β π 0 π 0 π¬ 0 π 0That's really amazing! Hope this helps
www.openevidence.com/ask/47b4d834...
Some background on current limited TX options:
www.openevidence.com/ask/a94c01ac...
However, there is a recently opened clinical trial for this rare disease
clinicaltrials.gov/study/NCT061...
@jerryclee.bsky.social
Some mechanistic background:
www.openevidence.com/ask/07ad3d33...
A short review of where we were at prior to this trial
www.openevidence.com/ask/1e95f6d9...
The New England Journal of Medicine CRISPR-Based Therapy for Hereditary Angioedema A PLAIN LANGUAGE SUMMARY Illustration of a patient with hereditary angioedema and NTLA-2002, a nonviral gene-editing therapy based on CRISPRCas9, for treatment. Read the full Plain Language Summary at NEJM.org.
In a new phase 2 trial, researchers evaluated the efficacy of a gene-editing therapy, NTLA-2002, in preventing angioedema attacks in patients with hereditary angioedema. Full trial results and Plain Language Summary: nej.md/4heR7hT
#MedSky #Oncology
www.openevidence.com/ask/55b54926...
05.02.2025 02:34 β π 0 π 0 π¬ 0 π 0As a primary care doctor & clinical informatician, I love using @openevidence.bsky.social during my clinic visits to review latest guidelines with patients & sources.
I strongly believe this practice helps build stronger therapeutic relationship with the doctor + AI assisted CDS. #CI=AI
Thanks so much for the shoutout. Ask for a patient summary. We will provide the information at an appropriate and inclusive reading level and can accommodate many languages
05.02.2025 02:27 β π 1 π 0 π¬ 1 π 0Other prior trials looking at the pros and cons of bridging AC peri-procedures
www.openevidence.com/ask/67491f3f...
Specific evidence for role in CRC:
www.openevidence.com/ask/c64de7c9...
We do keep our index updated daily so the most recent cdc pubs and mmwr will continue to be available for answers even if removed from CDC website
01.02.2025 22:49 β π 1 π 1 π¬ 0 π 0These A.I. models are rapidly changing life science.
A brief, open-access review of the remarkable progress in @science.org this week
www.science.org/doi/10.1126/...
We index CDC and WHO daily so we have to most recent publications for all these guidelines
01.02.2025 22:40 β π 1 π 0 π¬ 1 π 0For whom it make concern, with recent disruptions to CDC published information, we keep our index of this information updated daily, so will always have the most updated recommendations
01.02.2025 22:39 β π 0 π 0 π¬ 0 π 0Background on HE: www.openevidence.com/ask/0dbb7c4c...
30.01.2025 23:47 β π 0 π 0 π¬ 0 π 0